Study directory

Mental health studies with practical context.

Compare studies and check their requirements with the research team.

Back to overview
More filters: keywords, city, remote
10612studies shown
Showing 3,013-3,024 of 10,612
Drug study icon
CompletedNCT01009047

Extended-Release (ER) Paliperidone for schizophrenia

This study is completed in the United States, in India, in Romania, .... It is testing Extended-Release (ER) Paliperidone for schizophrenia.

In United States
SchizophreniaDrugA study involving a medication or substance.From 12 Years to 17 Years
Countries
United States, India, Romania, ...
Sponsor
Janssen Research & Development, LLC
Condition
Schizophrenia
Drug study icon
CompletedNCT00524043

One Dosage of Paliperidone Extended Release (ER) for schizophrenia

This study is completed in the United States, in India, and in Taiwan. It is testing One Dosage of Paliperidone Extended Release (ER) for schizophrenia.

In United States
SchizophreniaDrugOver 18 Years
Countries
United States, India, Taiwan
Sponsor
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Condition
Schizophrenia
Drug study icon
CompletedNCT02473289

Sirukumab for depression

This study is completed in the United States, in Canada, in the United Kingdom, .... It is testing sirukumab for depression.

In United States
DepressionDrugFrom 21 Years to 64 Years
Countries
United States, Canada, United Kingdom, ...
Sponsor
Janssen Research & Development, LLC
Condition
Depression
Drug study icon
CompletedNCT02498392

Safety study of JNJ-42165279 in depression

This study is completed in the United States, in the United Kingdom, in Moldova, .... It is testing JNJ-42165279 for depression.

In United States
Depression, AnxietyDrugFrom 18 Years to 64 Years
Countries
United States, United Kingdom, Moldova, ...
Sponsor
Janssen Research & Development, LLC
Condition
Depression, Anxiety
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.